NCT03053635
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +14 more
- Locations
-
- University Health Network Toronto, Ontario, Canada
Clinical trial condition
Explore clinical trials studying Non-Muscle Invasive Bladder Cancer (NMIBC) Refractory to BCG. Study availability and eligibility vary by location and protocol.
NCT03053635